Myelodysplastic syndrome (MDS) is defined by inadequate hematopoiesis and a risk of progression to acute myeloid leukemia (AML). This case report describes a 59-year-old individual with MDS who has a complicated karyotype that includes chromosomal 1q triplication (q21q32) and grade 2 myelofibrosis (MF-2).

Data of patients alive 10 years after inital treatement for multiple myeloma (MM) were collected by 13 Italian hematological centers from January 2020 to December 2022. Routine work-up at diagnosis and type of treatment of 201 patients were analyzed from December 2023 to March 2024.

Short-term outcomes of critically ill patients with hematological malignancies (HM) who developed acute kidney injury (AKI) is grim. Little is known about their long-term management. We aimed to assess the impact of the occurrence of AKI on long-term outcome and management in those patients

Sézary syndrome is characterized by erythroderma, diffuse adenopathy, atypical T lymphocytes in the blood (> 1000/µ Liter), and a dominant T clone in the blood, skin, and lymph nodes. Sézary syndrome is rare (3% of cutaneous T-cell lymphomas). There have been hospital-based studies in Africa, but there is no estimate of its frequency

The relationship between blood groups and diseases has been a subject of interest for many researchers. This study aims to investigate the susceptibility of each blood group to anemia based on the relationship between the erythrocyte indices and the biochemical parameters used to diagnose anemia.

The current case report illustrates role of vigilant laboratory services that helped in unmasking asymptomatic HbE variant in a middle aged known diabetic woman who came as an outdoor patient and on subsequent HbA1c testing was found to have lower value -2.9 %. It triggered extensive workup after looking for common causes and an electrophoresis of Hemoglobin revealed HbE variant.

Bloodstream infections(BSI) are one of severe infectious complications faced by hematopoietic stem cell transplantation(HSCT) patients.

Sickle cell disease (SCD) is a genetic hemoglobin disease for which there are many treatment options. Evidence supports the efficacy and cost-effectiveness of hydroxyurea (HU). Nevertheless, its use and adherence to treatment remain suboptimal, hence, the necessity to assess the factors influencing this observance.

Pediatric cancer overall survival has increased due to improvements in treatment. However, long-term adverse effects are a challenge for this population. Secondary myeloid neoplasm (MN) is one of the complications of solid tumor treatment. Therapy-related myeloid neoplasms (t-MN), therapy-related acute myeloid leukemia (t-AML), and therapy-related myelodysplastic syndrome (t-MDS) are the most common events

Morphologically abnormal blood cells in peripheral blood of a person reflect underlying pathological condition affecting formation, function, and lifespan of these cells